berberine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Notably, compared with the placebo, BBR did not change fasting blood glucose (FBG), fasting insulin or fasting proinsulin C-peptide levels (Supplementary Table 2).”
Quoted verbatim from Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.. - Study
- crossover
- Participants
- 15
- Dose
- single oral dose of 1 g berberine tablets
- Population
- 15 healthy men with normal glucose tolerance; secondary observation in a single-dose hyperglycaemic clamp trial, fasting glucose measured after an overnight fast before and after dosing
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.2021PMID:34556670Permalink
Keep reading
- Everything the graph holds on berberine
- Every compound studied against Fasting blood glucose
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0Z5JBWTTJCXF69E58N58DQ4